IL13RA2 and breast carcinoma: In the present study, we evaluated prophylactic and therapeutic effect of the IL-13Rα2 cDNA vaccination in syngeneic animal models of D5 melanoma, MCA304 sarcoma and 4T1 breast cancer cells expressing IL-13Rα2 to prime the immune system.